Danaher Corporation (NYSE:DHR) traded ~1% lower in the premarket on Tuesday as investors reacted to the life sciences company ...

Danaher posted improved results across key metrics in its latest quarter, which it attributed to momentum in its bioprocessing unit and demand above expectations in its molecular diagnostics business.

Danaher Corp. DHR) on Tuesday reported first-quarter profit of $954 million. The Washington-based company said it had profit of $1.32 per share.

Danaher Corporation (the "Company") today announced results for the quarter ended March 28, 2025. Key First Quarter 2025 Results Net earnings were $1.0 billion, or $1.32 per diluted common share and ...

Danaher beat Wall Street estimates for first-quarter profit on Tuesday, on the back of better-than-expected demand for its respiratory testing kits, and said it expects to incur additional ...

Ally Financial just cranked its Danaher investment up by 275%, grabbing 15,000 shares worth $3.44 million. Several other ...

ADCC World Medalist Luke Griffith has been promoted to black belt in Brazilian jiu-jitsu by Professor John Danaher ...

Shares of Danaher Corp. DHR slipped 1.00% to $184.96 Monday, on what proved to be an all-around dismal trading session for ...

Because of Keysight’s strong ESG reporting and oversight of ESG issues, Sustainalytics gives the company an ESG Risk ...

A total of 9 analyst ratings have been received for Danaher, with the consensus rating being Outperform. The average one-year ...

DHR's first-quarter earnings are likely to have been aided by strength in the Biotechnology segment. However, weakness in the ...

In a report released yesterday, Puneet Souda from Leerink Partners maintained a Buy rating on Danaher (DHR – Research Report), with a price ...